SAN DIEGO–Cytori Therapeutics (NASDAQ:CYTX) has been informed that the United States Federal Court in the Central District of California upheld a June 2008 decision relating to U.S. patent number 6,777,231 (the ‘231 patent). The Court’s decision has no impact on Cytori’s products or clinical applications under development. Cytori’s products do not practice the ‘231 patent. […]

University of Lódz invests in the unique Cellaxess®HT System for research on multidrug resistance genes in cancer Gothenburg, Sweden, July 22, 2009 — Cellectricon, a leading provider of cell-based screening solutions for research and drug discovery, today announced its collaboration with University of Lódz, Poland. Under the agreement University of £ódŸ invests in Cellaxess®HT, the […]

Fluxion Biosciences Awarded NCI Grant for Development of Rare Cell Isolation Platform Microfluidic Technology Has Potential Applications in Oncology, Immunology, and Neonatal Care SAN FRANCISCO–Fluxion Biosciences, a leading developer of microfluidic systems for cellular analysis in life science research, today announced that it has received a $200K grant from the National Cancer Institute (NCI) for […]

ANN ARBOR, Mich.–Essen Instruments Inc. announced today the establishment of a European Discovery Services operation and corresponding business site at the Biopark, Welwyn Garden City, UK. The new facility, headed by Dr. Del Trezise, will provide contract and collaborative services for drug discovery based initially around ion channels and Essen’s pioneering platform technologies including IonWorks […]

Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing Greater Than 90 Percent Cell Type Purification Enabled Through Exclusively Licensed Technology MADISON, Wis., July 15, 2009 –Cellular Dynamics International (CDI) today announced that it has exclusively in-licensed a US-issued patent portfolio on optimizing the stem cell differentiation selection process […]

Funds Will Provide Additional Working Capital to Support Strong Market Demand for Accuri C6 Flow Cytometer(R) System and Accuri CSampler(TM)– ANN ARBOR, Mich., July 13 — Accuri Cytometers, Inc. today announced the completion of a $4 million Series D financing. The financing included current investors Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures, […]

New Flow Cytometry-based Methods For Stem Cell Research Presented At Annual International Society For Stem Cell Research Meeting New data presented by BD Biosciences, a segment of BD (Becton, Dickinson and Company), at the International Society for Stem Cell Research (ISSCR) 7th Annual Meeting in Barcelona, Spain, highlights two novel flow cytometry-based sorting and analysis […]

Millipore to Distribute BioTime’s Novel ACTCellerate™ Human Progenitor Cells ALAMEDA, Calif.–BioTime, Inc. (OTCBB:BTIM) today announced that Millipore Corporation and BioTime’s subsidiary Embryome Sciences, Inc., have entered into a co-marketing agreement whereby Millipore will become a worldwide distributor of ACTCellerate™ human progenitor cell lines. Derived from human embryonic stem cells but not fully differentiated into specific […]

Dublin, Ireland — Cellix Ltd and Crisel Instruments today announced a distribution agreement that enables Crisel Instruments to distribute Cellix’s microfluidic products throughout Italy. Cellix’s Vivienne Williams, CEO noted that “Cellix is delighted to partner with Crisel Instruments to make our products available to the active research community in Italy” Crisel Instruments is a leading […]

Cell Resource Center Provides Access to the World’s Most Comprehensive Source for Cell Biology Research Tools CARLSBAD, Calif.–Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the launch of the life-science industry’s first comprehensive online resource for cell biology information and technology. The Invitrogen Cell Resource Center is a Web portal that brings together educational […]